The Role of PGE2 in Alveolar Epithelial and Lung Microvascular Endothelial Crosstalk

[1]  V. Kónya,et al.  The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation. , 2016, Vascular pharmacology.

[2]  N. Ferreirós,et al.  Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease. , 2016, Journal of Crohn's & colitis.

[3]  S. Dahlén,et al.  Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung , 2016, The Journal of allergy and clinical immunology.

[4]  K. Tomer,et al.  Contribution of alveolar type II cell‐derived cyclooxygenase‐2 to basal airway function, lung inflammation, and lung fibrosis , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  A. Olschewski,et al.  Activation of EP4 receptors prevents endotoxin‐induced neutrophil infiltration into the airways and enhances microvascular barrier function , 2015, British journal of pharmacology.

[6]  Donald F. Proctor,et al.  The Pathway for Oxygen, Structure, and Function in the Mammalian Respiratory System , 2015 .

[7]  M. Belvisi,et al.  Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype , 2015, Thorax.

[8]  Arthur S Slutsky,et al.  Human alveolar epithelial type II cells in primary culture , 2015, Physiological reports.

[9]  Dolly Mehta,et al.  Mechanisms Regulating Endothelial Permeability , 2014, Pulmonary circulation.

[10]  M. Krasnow,et al.  Alveolar progenitor and stem cells in lung development, renewal and cancer , 2014, Nature.

[11]  S. Herold,et al.  Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[12]  V. Kónya,et al.  E-type prostanoid receptor 4 (EP4) in disease and therapy , 2013, Pharmacology & therapeutics.

[13]  Arthur S Slutsky,et al.  Acute respiratory distress syndrome: new definition, current and future therapeutic options. , 2013, Journal of thoracic disease.

[14]  R. Malthaner,et al.  Human Alveolar Epithelial Cells Attenuate Pulmonary Microvascular Endothelial Cell Permeability under Septic Conditions , 2013, PloS one.

[15]  V. Kónya,et al.  Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking. , 2013, The Journal of allergy and clinical immunology.

[16]  Wan-Ling Wu,et al.  ATP Mediates NADPH Oxidase/ROS Generation and COX-2/PGE2 Expression in A549 Cells: Role of P2 Receptor-Dependent STAT3 Activation , 2013, PloS one.

[17]  Kerstin Pingel,et al.  50 Years of Image Analysis , 2012 .

[18]  M. Wirth,et al.  Lung endothelial cells strengthen, but brain endothelial cells weaken barrier properties of a human alveolar epithelium cell culture model. , 2012, Differentiation; research in biological diversity.

[19]  W. Seeger,et al.  Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation , 2012, Cancer Immunology, Immunotherapy.

[20]  A. Birukova,et al.  Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury , 2012, European Respiratory Journal.

[21]  K. Abe,et al.  Extract from Nandina domestica inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in human pulmonary epithelial A549 cells. , 2012, Biological & pharmaceutical bulletin.

[22]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[23]  M. Hellmich,et al.  NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope. , 2012, International journal of cardiology.

[24]  Y. Daaka,et al.  PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway. , 2011, Blood.

[25]  Yan Sun,et al.  Sudan black B reduces autofluorescence in murine renal tissue. , 2011, Archives of pathology & laboratory medicine.

[26]  M. Matthay,et al.  The acute respiratory distress syndrome: pathogenesis and treatment. , 2011, Annual review of pathology.

[27]  V. Kónya,et al.  Endothelium-derived prostaglandin I(2) controls the migration of eosinophils. , 2010, The Journal of allergy and clinical immunology.

[28]  B. Han,et al.  Cardiovascular , Pulmonary and Renal Pathology Functions of Type II Pneumocyte-Derived Vascular Endothelial Growth Factor in Alveolar Structure , Acute Inflammation , and Vascular Permeability , 2010 .

[29]  R. Senior,et al.  Characterization of mouse alveolar epithelial cell monolayers. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[30]  W. Seeger,et al.  Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[31]  Jie Zhou,et al.  Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells , 2009, Molecular Cancer Research.

[32]  J. Roca‐Ferrer,et al.  An intranasal selective antisense oligonucleotide impairs lung cyclooxygenase-2 production and improves inflammation, but worsens airway function, in house dust mite sensitive mice , 2008, Respiratory research.

[33]  T. Martin,et al.  Animal models of acute lung injury , 2008, American journal of physiology. Lung cellular and molecular physiology.

[34]  G. Hoefler,et al.  Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2 receptors , 2008, Journal of neurochemistry.

[35]  A. Malik,et al.  Regulation of Endothelial Junctional Permeability , 2008, Annals of the New York Academy of Sciences.

[36]  S. Donnini,et al.  Prostaglandin E2 Regulates Angiogenesis via Activation of Fibroblast Growth Factor Receptor-1* , 2008, Journal of Biological Chemistry.

[37]  G. Geisslinger,et al.  LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples. , 2006, Prostaglandins & other lipid mediators.

[38]  A. Pozzi,et al.  EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival , 2006, Oncogene.

[39]  P. Maasilta,et al.  COX-2 is widely expressed in metaplastic epithelium in pulmonary fibrous disorders. , 2006, American journal of clinical pathology.

[40]  Ian Parker,et al.  Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo , 2006, Nature chemical biology.

[41]  Dieter Huesken,et al.  Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. , 2005, Cellular signalling.

[42]  X. Fang,et al.  Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells , 2005, Respiratory research.

[43]  H. Kessler,et al.  Cyclooxygenase inhibition in human monocytes increases endotoxin-induced TNF alpha without affecting cyclooxygenase-2 expression. , 2004, European journal of pharmacology.

[44]  Kirsten Peters,et al.  Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro , 2004, Laboratory Investigation.

[45]  M. Peters-Golden,et al.  Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[46]  M. Peters-Golden,et al.  Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. , 2002, American journal of respiratory cell and molecular biology.

[47]  A. Verin,et al.  Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. , 2001, The Journal of clinical investigation.

[48]  Soken Tsuchiya,et al.  The Expression of Prostaglandin E Receptors EP2 and EP4 and Their Different Regulation by Lipopolysaccharide in C3H/HeN Peritoneal Macrophages1 , 2001, The Journal of Immunology.

[49]  J. Saklatvala,et al.  Dexamethasone Destabilizes Cyclooxygenase 2 mRNA by Inhibiting Mitogen-Activated Protein Kinase p38 , 2001, Molecular and Cellular Biology.

[50]  Heinz Fehrenbach,et al.  Alveolar epithelial type II cell: defender of the alveolus revisited , 2001, Respiratory research.

[51]  S. Belinsky,et al.  Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions. , 2000, Carcinogenesis.

[52]  H. Karahashi,et al.  Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. , 1998, Biochemical and biophysical research communications.

[53]  A. Brody,et al.  Isolation and primary culture of murine alveolar type II cells. , 1996, American journal of respiratory cell and molecular biology.

[54]  B. Vargaftig,et al.  Effect of cyclo‐oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide‐induced neutrophil infiltration in mouse lung , 1996, British journal of pharmacology.

[55]  J. Vane,et al.  Induction of cyclo‐oxygenase‐2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone , 1994, British journal of pharmacology.

[56]  O. Fardel,et al.  Regulation by dexamethasone of P‐glycoprotein expression in cultured rat hepatocytes , 1993, FEBS letters.

[57]  R. Flower,et al.  Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J W Gray,et al.  An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine. , 1987, Cytometry.

[59]  M. Belvisi,et al.  Anti-in fl ammatory effects of PGE 2 in the lung: role of the EP 4 receptor subtype , 2015 .

[60]  T. Hla,et al.  S1P control of endothelial integrity. , 2014, Current topics in microbiology and immunology.

[61]  J. Allard,et al.  Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells. , 2013, Microvascular research.

[62]  C. Vancheri,et al.  The lung as a privileged site for the beneficial actions of PGE2. , 2004, Trends in immunology.

[63]  D. Hougaard,et al.  Microwaving for double indirect immunofluorescence with primary antibodies from the same species and for staining of mouse tissues with mouse monoclonal antibodies , 2000, Histochemistry and Cell Biology.

[64]  W. Seeger,et al.  Type II alveolar epithelial eicosanoid metabolism: predominance of cyclooxygenase pathways and transcellular lipoxygenase metabolism in co-culture with neutrophils. , 1992, American journal of respiratory cell and molecular biology.

[65]  R. A. Parent,et al.  Comparative biology of the normal lung , 1992 .

[66]  R. J. Stephens,et al.  Renewal of alveolar epithelium in the rat following exposure to NO2. , 1973, The American journal of pathology.